SCHEMBL8582471

SCHEMBL8582471

CCCCOCCCN1CNCNC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
HRH3 Q9Y5N1 3/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM1 P11229 1/20 0.37
HTR2A P28223 1/20 0.37
SCN1A P35498 1/20 0.37
HTR2B P41595 1/20 0.37
KCNH2 Q12809 1/20 0.37
SCN2A Q99250 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
SCN3A Q9NY46 1/20 0.37
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.34
GNAO1 P09471 5/20 0.34
GNAI3 P08754 4/20 0.34
GNAI1 P63096 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28935040 0.86 ALDH1A1 (0.34) ALDH1A1
SCHEMBL6557162 0.83 GLB1 (0.40) ALDH1A1CYP1A2SIGMAR1GNAO1GNAI3
SCHEMBL20418301 0.81 GNAO1 (0.43) ALDH1A1CYP1A2SIGMAR1GNAO1GNAI3
SCHEMBL3313743 0.79 GNAO1 (0.46) TSHRALDH1A1CYP1A2SIGMAR1GNAO1
SCHEMBL3310643 0.79 GNAO1 (0.46) TSHRALDH1A1CYP1A2SIGMAR1GNAO1
SCHEMBL8751413 0.79 GNAO1 (0.46) TSHRALDH1A1CYP1A2SIGMAR1GNAO1
SCHEMBL8392333 0.78 HRH2 (0.40) TSHRHRH3MAPK1ALDH1A1CYP1A2
SCHEMBL11571542 0.77 HRH3 (0.50) TSHRHRH3MAPK1ALDH1A1CYP1A2
SCHEMBL8587238 0.77 TSHR (0.46) TSHRHRH3MAPK1ALDH1A1CYP1A2
Hydrochloric Acid SCHEMBL27558043 0.76 GNAO1 (0.43) ALDH1A1CYP1A2SIGMAR1GNAO1GNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109310982-B Composition for removing sulfur-containing compounds 株式会社可乐丽(JP) 2023-01-13 CN disclosed
CN-107207974-B The composition of sulfur-containing compound removing 株式会社可乐丽 2019-11-15 CN disclosed
EP-3283600-B1 METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN LIQUID OR GASEOUS STREAMS USING COMPOSITIONS COMPRISING TRIAZINES AND ANIONIC SURFACTANTS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-09-25 EP disclosed
US-10155911-B2 Method of reducing hydrogen sulfide levels in gaseous mixtures using triazines DOW GLOBAL TECHNOLOGIES LLC (US) 2018-12-18 US disclosed
EP-3283600-A1 METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN LIQUID OR GASEOUS STREAMS USING COMPOSITIONS COMPRISING TRIAZINES AND ANIONIC SURFACTANTS Dow Global Technologies LLC (US) 2018-02-21 EP disclosed
US-20180044598-A1 METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN GASEOUS MIXTURES USING TRIAZINES DOW GLOBAL TECHNOLOGIES LLC 2018-02-15 US disclosed
CN-107207974-A The composition of sulfur-containing compound removing 株式会社可乐丽 2017-09-26 CN disclosed
WO-2016167994-A1 METHOD OF REDUCING HYDROGEN SULFIDE LEVELS IN LIQUID OR GASEOUS STREAMS USING COMPOSITIONS COMPRISING TRIAZINES AND ANIONIC SURFACTANTS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-10-20 WO disclosed
US-5744024-A SCAVENGING USING MIXTURE OF HEXAHYDRO-1,3,5-TRIAZINE AND QUATERNARY AMMONIUM COMPOUND NALCO/EXXON ENERGY CHEMICALS, L.P. (US) 1998-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10155911-B2 Method of reducing hydrogen sulfide levels in gaseous mixtures using triazines TST, GSS, SCLY TSHR 693/4885HRH3 1320/4885MAPK1 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.